Atazanavir en es it fr

Atazanavir Brand names, Atazanavir Analogs

Atazanavir Brand Names Mixture

  • No information avaliable

Atazanavir Chemical_Formula


Atazanavir RX_link

Atazanavir fda sheet

Atazanavir FDA

Atazanavir msds (material safety sheet)

Atazanavir Synthesis Reference

No information avaliable

Atazanavir Molecular Weight

704.856 g/mol

Atazanavir Melting Point

No information avaliable

Atazanavir H2O Solubility

Free base slightly soluble (4-5 mg/mL)

Atazanavir State


Atazanavir LogP


Atazanavir Dosage Forms

Capsule (100 mg, 150 mg, or 200 mg)

Atazanavir Indication

For use, in combination with other antiretroviral agents, in the treatment of HIV-1 infection.

Atazanavir Pharmacology

Atazanavir (ATV) is an azapeptide HIV-1 protease inhibitor (PI). It is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part of HIV called protease. HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Atazanavir binds to the protease active site and inhibits the activity of the enzyme. This inhibition prevents cleavage of the viral polyproteins resulting in the formation of immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs.

Atazanavir Absorption

Atazanavir is rapidly absorbed with a Tmax of approximately 2.5 hours. Administration of atazanavir with food enhances bioavailability and reduces pharmacokinetic variability

Atazanavir side effects and Toxicity

No information avaliable

Atazanavir Patient Information

Atazanavir Organisms Affected

Human immunodeficiency virus